Elon Musk drew a reaction from broadcaster Megyn Kelly after announcing Neuralink's second product, Blindsight, which aims to help blind people regain visual perception.Musk said on October 30, 2026, that the technology was engineering-ready and awaiting regulatory approval. Kelly responded to his announcement by writing,“This is the man the Left regularly tries to villainize and wants thrown in jail.”Elon Musk described Blindsight as a product intended to enable people who are completely blind, including those who have never seen, to see. Neuralink's website says the technology is designed to generate visual perception by stimulating brain areas responsible for vision.Megyn Kelly @megynkellyLINKThis is the man the Left regularly tries to villainize and wants thrown in jail.The company has received FDA Breakthrough Device Designation for the device, but it has not received regulatory approval.Elon Musk announces Neuralink's BlindsightElon Musk described Blindsight as Neuralink's second product. He said the device would enable people who are completely blind or have never seen to experience visual perception. Musk added that the technology was ready from an engineering standpoint, with regulatory approval remaining the next step.Elon Musk @elonmuskLINKOur second product is called Blindsight and it will, as the name suggests, enable even those who are completely blind or have never seen to see.It is ready from an engineering standpoint. Just waiting on regulatory approval.The announcement followed an earlier post in which Elon Musk introduced Neuralink's first product, Telepathy. He described it as a brain-computer interface that enables high-speed communication with computers or humans through thought.Musk said its output bandwidth would eventually exceed the fastest human speech or typing, although he did not provide a specific timeline beyond saying this could happen within a few years.The two posts drew attention to Neuralink's expanding work on brain-computer interfaces. While Telepathy is designed to allow users to communicate with computers through neural activity, Blindsight is intended to address visual impairment by transmitting information directly to the brain.Both products remain subject to development and regulatory requirements.How Neuralink's Blindsight technology is designed to restore visual perceptionAccording to Neuralink's website, Blindsight aims to generate visual perception by activating brain regions responsible for visual function.Under normal conditions, the retina at the back of the eye converts light into electrical signals, which the brain processes to create the perception of the surrounding world. Injuries or diseases affecting the eyes or optic nerves can interrupt this process and lead to partial or complete loss of vision.Neuralink's proposed approach is to bypass the natural pathway between the eyes and the brain. The system uses a video camera to capture images of a person's surroundings or loved ones. It then wirelessly transmits the information to the brain through a specialised implant, stimulating areas associated with visual function.The company says it has received the US FDA's Breakthrough Device Designation for Blindsight. This designation is intended to accelerate the development and review process for devices addressing serious conditions. However, it does not mean that the product has been approved for general use or that its effectiveness has been established.Neuralink is inviting interested individuals to join its patient registry to receive information about future clinical trials for visual prostheses in the United States. The company has not announced a confirmed date for the start of those trials at the time of press.Read More: How much did Elon Musk pay for Twitter? Sneako accuses SpaceX boss of using it to allegedly spread "Mossad propaganda"